PHENYLMETHYLSILOXANE-DIMETHYLSILOXANE COPOLYMER, 500 cSt, 100g

ethyl 2-((5R)-5-isopropyl-3,6-dimethoxy-2,5-dihydropyrazin-2-yl)acetate, 98%, 500mg

tert-Butyl 4-(4-nitropyridin-2-yl)piperazine-1-carboxylate, 95.0%, 5g

1-(5-Methylfuran-2-yl)ethanone, 98.0%, 500g

4-Chloro-5-Fluoroquinazoline, 95.0%, 1g

RHAPONTICIN, 95%, 100mg

(S)-Benzyl 4-oxoazetidine-2-carboxylate, 95.0%, 100mg

2-(1-Methyl-1H-pyrazol-4-yl)ethan-1-ol, 95.0%, 25g

1-Bromo-2-chloro-4-(trifluoromethoxy)benzene, 95.0%, 250mg

1-(1,3-benzothiazol-2-yl)azetidine-3-carboxylic acid, 95.0%, 500mg

6-Chlorobenzo[d]thiazole-2-carbonitrile, 95%, 100mg

(2R,3R,4S,5S,6R)-2-(((2R,3S,4R,5R,6R)-6-(Dodecyloxy)-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, 97%, 25g

3-Fluoro-N-methylbenzamide, 95.0%, 5g